Screener
Summit Therapeutics SMMT Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Summit Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The source filing: Summit Therapeutics’s 10-Q, filed April 30, 2026.
- Filed
- Apr 30, 2026, 5:00 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001599298-26-000039
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Restricted cash | 316 | 316 |
| Short-term investments | 492,216 | 488,182 |
| Prepaid expenses and other current assets | 17,551 | 6,537 |
| Total current assets | 616,598 | 720,301 |
| Non-current assets: | ||
| Property and equipment, net | 1,664 | 1,059 |
| Operating lease right-of-use assets | 19,398 | 20,616 |
| Goodwill | 1,965 | 2,001 |
Item 1. Financial Statements.
FAQ
- What is Summit Therapeutics's total current assets?
- Summit Therapeutics (SMMT) reported total current assets of $616.6M in Q1 2026.
- How has Summit Therapeutics's total current assets changed year-over-year?
- Summit Therapeutics's total current assets increased by 66.3% year-over-year, from $370.75M to $616.6M.
- What is the long-term trend for Summit Therapeutics's total current assets?
- Over 5 years (2020 to 2025), Summit Therapeutics's total current assets has grown at a 52.4% compound annual growth rate (CAGR), from $87.67M to $720.3M.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.
Ask your AI about Summit Therapeutics's total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude